We have developed "high-performance" liquid-chromatographic methods for determining 4-aminopyridine, an acetyicholine-releasing drug, in serum, saliva, and urine. As little as 1 j.tg/L can be detected by extracting the alkalinized sample plus the internal standard (3,4-diaminopyridine) into dichloromethane, mixing the organic phase with 1-pentanol, evaporating the dichloromethane, and injecting the residue onto a reversed-phase column, where it is eluted with acetonitrile/methanol/aqueous ammonium carbonate, with detection at 245 nm. Analytical recoveries from serum averaged 86.7%. The CV at 50 .tg/Lwas 2.9% (n = 8).For urine samples containingvery high concentrationsof 4-aminopyridine,we mixed urineand potassium carbonate in an automatic injector vial,extracted the drug into dichloromethane, centrifuged, and injected an aliquot of the extract into the chromatograph.
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We have developed "high-performance" liquid-chromatographic methods for determining 4-aminopyridine, an acetyicholine-releasing drug, in serum, saliva, and urine. As little as 1 j.tg/L can be detected by extracting the alkalinized sample plus the internal standard (3,4-diaminopyridine) into dichloromethane, mixing the organic phase with 1-pentanol, evaporating the dichloromethane, and injecting the residue onto a reversed-phase column, where it is eluted with acetonitrile/methanol/aqueous ammonium carbonate, with detection at 245 nm. Analytical recoveries from serum averaged 86.7%. The CV at 50 .tg/Lwas 2.9% (n = 8).For urine samples containingvery high concentrationsof 4-aminopyridine,we mixed urineand potassium carbonate in an automatic injector vial,extracted the drug into dichloromethane, centrifuged, and injected an aliquot of the extract into the chromatograph. , and myasthenia gravis (6) . A method for preparing a 4-aminopyridine solution for injection is given by Uges and Huizinga (7). Pymidin#{174} ampoules contain 10mg of 4-aminopyridine hydrochloride in 2 mL of solution for injection.
The existing gas-chromatographic methods, intended for determination of 4-AP in animal tissues (8) and in seeds (9) , are inadequate for the determination in body fluids or for routine analyses in clinical laboratories.
Evenhuis et al. (10) developed a gas-chromatographic method, which they have used in preliminary pharmacokinetic studies of 4-AP in man, but this method has some disadvantages, such as the relatively time-consuming purification step, low analytical recovery, and the lack of an internal standard. Therefore, we have developed an easy "high-performance" liquid chromatographic method for determination of 4-AP in body fluids, which has proven suitable for use in studies of pharmacokinetics and bioavailability of 4-AP in humans.
Materials and Methods

Reagents
All chemicalsused were of reagentgrade."Ultra-pure"
water (waterpurified with a "Miii Q" apparatus; Millipore at a flow speed of 0.5 cm/mm, input 10 mV and 100 mV. We packed the 15.0 cm X 3.0 mm (i.d.) stainless-steel column with a 5-zm (av. particle size) reversed-phase material (Nucleosil 5C18; Chrompack B.V., Middelburg, The Netherlands), using a balanced-density slurry technique (11) . All separations were done at ambient temperature.
Mobil Phase
We used a mixture of acetonitrile/methanol/aqueous (10 gIL) ammonium carbonate, 61/35/4by volume, which was degassed ultrasonically beforeuse. The flow rate was 0.8 mL/min.
Sample and internal standard solutions were pipetted with useofdisposable tips (P-70000 Sampler;Oxford Labs., Foster City,CA 94404); the standard solution was dispensed with an analytical syringe(S.G.E.; Chrompack B.V.)
For thegeneralmethod we used 10-mL testtubes.For the alternative method, we used disposable 4-mL WISP vials with self-sealing septa(WatersAssociates). For use in routine analyses, lyophilized calf's serum fortified with 100 g of4-AP per liter is very practicable as the standard (12) , and it is stable for at least one year. These standards and the patients' samples are treated exactly the same.
General Method for Determining
We used the ratios between the peak heights of 4-AP and the internal standard to construct the curves. Slopes and correlation coefficients were calculated by a least-squares procedure. analyzed withinone week were stored at -20 #{176}C. We saw no B breakdown of4-AP after three months of storage at -20 #{176}C. Saliva was vortex-mixed forabout 5s,and centrifuged before the upper layer was pipetted. 
Treatment of Specimens
Serum, saliva, and urinespecimens were storedat 4 #{176}C, 
Recovery Studies
Analytical recoveries for different concentrations of4-AP and oftheinternal standardwere determinedby addingthe internal standard or4-AP after theextraction and evaporation stepand assaying. The relative peak heightratios were calculated (R1) and compared with the ratio obtained by injecting a mixture of a known amount of 4-AP and internal standard onto the column (R2). The recovery is the ratio between R1 and R2 (X 100%). (Table 1) fordrug-supplemented pooledhuman serum determinedon different dayswas 0.9983 (CV 0.2%,n = 7) intherangeof50-800 jzglL, witha detection limit(definedas twicethe noiselevel) of about 1 igfL, a quantitation limit ofabout5 izgIL, and a recovery of4-AP (100 zg/L) in supplemented calf's serum of 86.7% (CV 5.9%,n = 9).We found an averagerecovery of the internal standard from water of82.7% (CV 7.5%,n = 10),but when 3,4-diaminopyridmne in dichloromethane was added to the alkalinized sample,the recoveryincreased to94.5% (CV 5.5%,n = 9). The alternative method suitable forurinehas a linear calibration curve, at least in the range 0.1-8 mg/L, for which the regressionequation is y = 0.06014x -2.5972; F (±CV) = 0.9999(±0.0082%), n = 6,intherangeof0.5-8 mg/L; a quantitation limit ofabout0.1mg/L, and recoveries from supplemented human urine in the range of 89-94% at 4-AP concentrations of 0.5-8 mg/L (n = 6 for each of five different concentrations). Table 1 
Results
Figure1
Interference
The only drug (ordrug metabolite) thatmight interfere with thismethod is quinidine. Table2 lists the drugs we tested forinterference. One volunteer smoked cigars during a kinetic study of 4-AP. In the chromatogram of some of his saliva samples we found an inexplicably high "4-AP peak";his serum chromatograms showed no such abnormality.
Development of the Method
Alkalination and extraction.
The hydrochloride of4-AP is very soluble inwater,and the base can also be dissolved in water. Therefore, we use as little water as possible and an excess of organic solvent. The mean recovery after alkalination of the serum with a potassium hydroxide solution (500 g/L)
was 99% (n = 5), better than the 87% (n = 5) recovery found after using dry potassium carbonate, but the linearity range of the calibration curves was unsatisfactory. The use of dry potassium carbonate has the advantage that there is no need to aspirate a water phase. The relative density of the aqueous layer (urine together with potassium carbonate) will be higher than that of the organic layer (mobile phase), and therefore, in the alternative method, removal of the water layer is not required. The end of the needle of the wisP isabove thewater layer, and the testvialcan be kept closed during the whole analysis.
The amount of potassium carbonateisnot very critical. Whether 200,300, or400mg ofpotassium carbonate was used, averagerecoveries (n = 10)for4-AP ranged from 85.4 to86.7% (CV 4.3to 5.9%)and for3.4-diaminopyridine from 94.3 to 94.5% (n = 10, CVs 5.5-5.8%). Because 4-AP isvolatile, the extraction fluid must have a low boiling point. An assessment of recoveries by this method with use of several different extraction solvents-heptane, diethyl ether, chloroform, and dichloromethane-showed the lastto be the best:for4-AP, 86.7% (CV, 5.9%); for 3,4-diaminopyridine 94.5% (CV, 5.5%). Indeed,it is a very useful extraction solvent for many volatile drugsand metabolites, particularly when evaporation under reduced pressureis used at low temperature (13) . The 1-pentanol isadded topreventtheextract from boiling dry,with lossofthe volatile drug.Samples with 4-AP concentrations >50 ig/L can be used without concentration, with a directinjection method: 0.1mL of serum or salivaand 0.6mL of internal standard (0.75mg of3,4-diaminopyridine per liter ofmobilephase)arevortex-mixed forlOs and centrifuged at 3000 rpm for5 mm, and 80 zL ofthesupernatantfluidisinjected onto the column.
Although this easy method has good linearity (y = 0.00308x + 0.01348; F = 0.9999, n = 5, range 50-800 g/L of serum), in practice ithastwo greatdisadvantages: most serum and saliva samples containtoo low a concentration of 4-AP forthis method and,ifurineisbeinganalyzed, thecolumn becomes pollutedafterthe first injection. Use of a precolumn might obviatethelatter problem.
The internal standard. Of thecompounds thatare commercially available, the most obvious for use as an internal standard, 2-aminopyridine and 3-aminopyridine, seem to behave quite differently from 4-aminopyridine. Although 3,4-diaminopyridine is more soluble in water than 4-AP, it is the only reliable internal standard that is readily available. The coefficient of correlation of the calibration curves decreased when no internal standard was used or when 3,4-diaminopyridine was added after the extraction procedure.
We use an automatic injector with a reproducible injection volume,sothealternative method doesnotrequire an internal standard,
because there isno aliquoting duringtheextraction.
In practice, this is proven by the very high correlation coefficient of the calibration curves (r = 0.9999). The column. Besides the reversed-phase method described here, we have also obtained good results for determination of 4-AP by using a 15 cm X 3.0 mm (i.d.) normal-phase column [5-tim particle size silica gel (11)1, with dichloromethane/ methanol/diethylamine (90/10/0.1 by vol) as mobile phase and 3-aminopyridine as internal standard. We generally prefer normal-phase systems because of their stability, convenience (such columns are easily and quickly prepared), and efficiency (the theoretical plate number is high for these adsorbents) (14, 15) . For determination of the highly polar compound 4-AP, we have chosen the reversed-phase method because of the shorter retention time and the better analytical recovery of the internal standard.
Detection.
4-AP has an absorption
maximum inwater at about 264 nm, with a high absorptivity (specific absorption coefficient), which is pH dependent; 3,4-diaminopyridine has its maximum at about 285 nm. With use of the mobile phase we describe, the optimal wavelength for 4-AP is 244-246 nm and for 3,4-diaminopyridine 242-256 nm. Therefore, we have used a multiwave detector at 245 nm. When we used a 254-nm fixed-wavelength detector (Waters Associates), the sensitivity decreased by 35%.
Of the new methods we describe for determination of the acetylcholine-releasing drug, 4-aininopyridine, in body fluids, one method is reliable for determination of 4-AP concentrations >5 zg/L in serum or saliva. Although one method is usable for urine samples, we describe an alternative (easy and adequate) method for determination of 4-AP in urine if preferred. Both methods are useful for kinetic and clinical studies and have advantages over previously published methods.
